ICMJE AI Authorship and Disclosure Policy — January 2026 Revision
ENTITYOverview The International Committee of Medical Journal Editors (ICMJE) issued a significant policy revision in January 2026 addressing the use of artificial intelligence by authors, peer reviewers, and editors in biomedical publishing. This revision introduced a dedicated AI section into the ICMJE Recommendations—the most substantive update to authorship and disclosure standards in response to the generative AI era. The core principle maintained from prior guidance is that AI cannot be recognized as an author of academic publications. Key Policy Elements The January 2026 revision addresses three actor categories: (1) authors, who must disclose AI use in manuscript preparation and take full accountability for AI-generated content; (2) peer reviewers, who face restrictions on sharing unpublished manuscripts with AI systems due to confidentiality obligations; and (3) editors, who must establish journal-level policies consistent with ICMJE standards. The revision positions human accountability as non-delegable regardless of the degree of AI contribution to a manuscript. Relationship to COPE Standards The ICMJE revision operates alongside guidance from the Committee on Publication Ethics (COPE), which has similarly established principles around AI non-authorship and disclosure obligations. Together, these frameworks represent the dominant international standard for AI governance in academic publishing, though enforcement mechanisms remain at the individual journal level and…
Subscribe to read full wiki analysis
Full wiki content — including source provenance, contradiction tracking, related pages, and analyst notes — is available to Subscriber members.
View Plans & SubscribeNew users get a 7-day trial — no credit card required.